Literature DB >> 29552941

Thigh arteriovenous grafts. Quantitative comparison with alternative options: A meta-analysis.

Miltos K Lazarides1,2, Christos Argyriou2, Andreas Koutsoumpelis2, Efstratios I Georgakarakos2, George S Georgiadis2.   

Abstract

Thigh arteriovenous grafts are required in a number of patients with exhausted upper extremity veins and comprise 1%-5% of the total access procedures performed. Alternative autogenous lower extremity options are the rarely used sapheno-tibial arteriovenous fistulae, the saphenous vein transpositions, and the femoral vein transpositions. The latter have proven to be the most durable lower limb access procedures, with low infection rates and their primary patency rates ranged from 74% up to 87% at 2 years. Synthetic thigh grafts are suitable for patients who are not good candidates for any upper limb or any autogenous lower limb access and their secondary patency rates ranged from 54% up to 83% at 2 years. Thigh grafts often get infected and their average weighed infection rate in 920 such grafts included in eight large series was 22.9%. A literature search was performed to evaluate thigh grafts compared with alternative options using meta-analysis. Lower limb accesses were found superior compared to HeRO® device regarding 1-year primary failure rate (odds ratio = 0.28, confidence interval = 0.09-0.88, p = 0.03) and additionally autogenous lower limb accesses were found superior compared to thigh grafts regarding the 1-year primary failure rate (odds ratio = 6.54, confidence interval = 2.29-18.72, p = 0.0005).

Entities:  

Keywords:  Thigh arteriovenous grafts; femoral arteriovenous access; lower limb access; meta-analysis

Mesh:

Year:  2018        PMID: 29552941     DOI: 10.1177/1129729818762991

Source DB:  PubMed          Journal:  J Vasc Access        ISSN: 1129-7298            Impact factor:   2.283


  1 in total

1.  Superficial femoral vein transposition as a solution for hemodialysis vascular access.

Authors:  Matheus Mannarino Carmo Silva Ribeiro; Eduardo Rodrigues; Alex Bezerra; Eric Paiva Vilela; Felipe Borges Fagundes; Cristiane Ferreira de Araújo Gomes; Cristina Ribeiro Riguetti Pinto; Carlos Eduardo Virgini-Magalhães
Journal:  J Vasc Bras       Date:  2022-10-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.